Company Search:
Advanced Search
Sponsored Links
Haemato AG Company Snapshot
Haemato AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haemato AG with three other pharmaceutical manufacturers in Europe: Dechra Pharmaceuticals PLC of the United Kingdom (2015 sales of £203.48 million [US$250.28 million] of which 83% was European Pharmaceuticals), OTCPharm PAO of Russia (17.85 billion Russian Rubles [US$285.34 million] ), and FAES Farma SA which is based in Spain (204.72 million Euro [US$224.72 million] of which 85% was Speciality Pharmaceuticals).

Sales Analysis. Haemato AG reported sales of 229.73 million Euro (US$252.17 million) for the year ending December of 2015. This represents an increase of 13.3% versus 2014, when the company's sales were 202.67 million Euro. This was the fourth straight year of sales growth at Haemato AG.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Haemato AG
  Stock Performance Chart for Haemato AG
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 5.10
(Figures in Euro)
1 Week 1.5%   13 Weeks 1.0%  
4 Weeks 4.1%   52 Weeks 12.8%  
Haemato AG Key Data:
  Ticker: HAE Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 229,727,262
(Year Ending Jan 2016).
Employees: 173
  Currency: Euro Market Cap: 105,972,380
  Fiscal Yr Ends: December Shares Outstanding: 20,778,898
  Share Type: Inhaberstammaktien Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.